Live Breaking News & Updates on Medical Sciences Venture
Stay updated with breaking news from Medical sciences venture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Agendia, Inc.: Agendia Appoints Ronald Andrews and David Schreiber to Board of Directors finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Agendia Appoints Ronald Andrews and David Schreiber to Board of Directors itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
(NASDAQ:PRPO) announces that Mr. Ron Andrews has joined the company s Board of Directors. As the company continues to build its products division around commercializing the technologies it has developed (such as HemeScreen and IV-cell), having additional resources and experienced industry veterans to support management s goals is key to its success and ongoing growth. Mr. Andrews brings a wealth of experience in the diagnostics world, and specifically in the areas of product development & commercialization. Some of Mr. Andrews past experiences includes Chief Commercial Officer at Roche Molecular; President of Genetic Science Division at Thermo Fisher Scientific; President of the Medical Sciences Venture at Life Technologies Corporation; and CEO of Clarient, which was acquired by GE Healthcare for $580M in 2010. ....